Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00087802 | Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 383 | SanofiINDUSTRY | 1 | Apr 16, 2009 | clinicaltrials |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse(SPEAR) | unknown | Phase 3 | 399 | Poniard PharmaceuticalsINDUSTRY | 15 | Apr 14, 2009 | clinicaltrials |
| Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions |
| unknown |
| — |
| 40 |
| Azienda Ospedaliero Universitaria Maggiore della CaritaOTHER |
| 1 |
| Apr 14, 2009 |
| clinicaltrials |
| NCT00497315 | Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)(PACCORA) | completed | Phase 2 | 30 | University Hospital, AntwerpOTHER | 1 | Apr 10, 2009 | clinicaltrials |
| NCT00115206 | Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | completed | Phase 4 | — | AmgenINDUSTRY | 0 | Apr 6, 2009 | clinicaltrials |
| NCT00102505 | A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 36 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00867412 | Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer | completed | — | 189 | Rigshospitalet, DenmarkOTHER | 1 | Mar 23, 2009 | clinicaltrials |
| NCT00579215 | Lung Cancer Informational Study (LCIS) | completed | N/A | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 18, 2009 | clinicaltrials |
| NCT00174369 | MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 34 | PfizerINDUSTRY | 1 | Mar 17, 2009 | clinicaltrials |
| NCT00043368 | PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) | completed | Phase 2 | 31 | PfizerINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00098085 | Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Agenus Inc.INDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00006347 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00006458 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00722969 | Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 48 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00585845 | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | terminated | Phase 1 | 17 | Anza Therapeutics, Inc.INDUSTRY | 2 | Feb 20, 2009 | clinicaltrials |
| NCT00675168 | Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice(PROLOG) | unknown | Phase 4 | 1,700 | Odense University HospitalOTHER | 1 | Feb 19, 2009 | clinicaltrials |
| NCT00845143 | Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer | unknown | — | 100 | Heidelberg UniversityOTHER | 0 | Feb 18, 2009 | clinicaltrials |
| NCT00846443 | Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00094822 | Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | — | 90 | AmgenINDUSTRY | 0 | Feb 13, 2009 | clinicaltrials |
| NCT00070629 | CPG 7909 Injection in Non-Small Cell Lung Cancer | completed | Phase 2 | 116 | PfizerINDUSTRY | 3 | Feb 10, 2009 | clinicaltrials |
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | unknown | Phase 3 | 280 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00006087 | Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer | unknown | N/A | — | Jewish Hospital and St. Mary's HealthcareOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00033410 | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | California Cancer ConsortiumNETWORK | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00077220 | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00270582 | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer | unknown | Phase 2 | 58 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00274898 | Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer | unknown | Phase 2 | 80 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00616499 | Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | unknown | Phase 2 | 35 | Yonsei UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00616785 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | unknown | Phase 2 | 41 | Yonsei UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00221169 | Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer | completed | Early Phase 1 | 31 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Feb 5, 2009 | clinicaltrials |
| NCT00434135 | Alimta and Gemcitabine in Non-Small Cell Lung Cancer(ANGEL) | completed | Phase 2 | 180 | Southern Italy Cooperative Oncology GroupOTHER | 1 | Feb 5, 2009 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00832494 | Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 105 | Antisoma ResearchINDUSTRY | 0 | Jan 30, 2009 | clinicaltrials |
| NCT00430651 | Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | completed | Phase 3 | 135 | Hellenic Oncology Research GroupOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | completed | Phase 1 | 15 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00828022 | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer(SMC4692) | unknown | Phase 1 / Phase 2 | 15 | Soroka University Medical CenterOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00116610 | Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | completed | Phase 2 | 75 | Poniard PharmaceuticalsINDUSTRY | 3 | Jan 21, 2009 | clinicaltrials |
| NCT00826033 | Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer | completed | — | — | Gunma UniversityOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00364624 | Adrenal Function in Patients With Newly Diagnosed Lung Cancer | completed | — | 133 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Jan 16, 2009 | clinicaltrials |
| NCT00142532 | Acupuncture for Post-Thoracotomy Pain | completed | Phase 3 | 162 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00820417 | Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib | completed | Phase 1 | 63 | Harrison Clinical ResearchINDUSTRY | 2 | Jan 12, 2009 | clinicaltrials |
| NCT00049790 | Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer | completed | Phase 2 | — | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00815971 | Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib | unknown | — | 300 | Aarhus University HospitalOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00290953 | Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide(SESAME) | completed | Phase 2 / Phase 3 | 432 | SanofiINDUSTRY | 14 | Dec 23, 2008 | clinicaltrials |
| NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 86 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00712504 | Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer | completed | Phase 1 | 49 | PfizerINDUSTRY | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00441740 | Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 419 | Hellenic Oncology Research GroupOTHER | 1 | Oct 31, 2008 | clinicaltrials |
| NCT00441922 | Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 3 | 166 | Hellenic Oncology Research GroupOTHER | 1 | Oct 29, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Apr 16, 2009source: clinicaltrials